| Direct Competitor Comparison | |
|---|
| ANIK | AGN | PVT1 | PVT2 | Industry |
|---|
| Market Cap: | 194.49M | 30.06B | N/A | N/A | 71.76B |
|---|
| Employees: | 106 | 11,100 | N/A | N/A | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.06 | 0.08 | N/A | N/A | 0.27 |
|---|
| Revenue (ttm):
| 72.24M | 5.92B | N/A | N/A | 13.93B |
|---|
| Gross Margin (ttm): | 0.62 | 0.87 | N/A | N/A | 0.72 |
|---|
| EBITDA (ttm): | 28.81M | 1.87B | N/A | N/A | 1.51B |
|---|
| Operating Margin (ttm):
| 0.33 | 0.29 | N/A | N/A | 0.13 |
|---|
| Net Income (ttm): | 12.91M | 1.14B | N/A | N/A | N/A |
|---|
| EPS (ttm): | 0.89 | 2.88 | N/A | N/A | 0.61 |
|---|
| P/E (ttm): | 16.20 | 35.21 | N/A | N/A | 18.43 |
|---|
| PEG (5 yr expected): | 0.44 | 1.53 | N/A | N/A | 1.51 |
|---|
| P/S (ttm): | 2.65 | 5.03 | N/A | N/A | 3.64 |
|---|
|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.88B | 31.52 |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- AGN
- Allergan About To Put More Money In Your Pocket (AGN) at Forbes Fri, May 17
- AGN
- Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care Innovation Wall Street Transcript Thu, May 16
- AGN
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward at TheStreet Thu, May 16
- AGN
- Why This Stock's Crash is a Buying Opportunity at Motley Fool Tue, May 14
- AGN
- ALLERGAN INC Financials EDGAR Online Financials Sat, May 11
All Headlines for these symbols... Currency in USD. | |
|
0.25(1.77%) May 17, 4:00PM EDT